Stephens & Co. Reiterates Overweight Rating on Matson, Inc. (MATX)
Rating Change Stephens & Co. analysts reiterated a Overweight rating on Matson, Inc. (NYSE:MATX) on August 04, 2026.
Read moreReal-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change Stephens & Co. analysts reiterated a Overweight rating on Matson, Inc. (NYSE:MATX) on August 04, 2026.
Read moreRating Change JP Morgan analysts reiterated a Overweight rating on Matson, Inc. (NYSE:MATX) on August 04, 2026. Market Context Matson, Inc.
Read moreRating Change UBS analysts upgraded BBB Foods Inc. (NYSE:TBBB) from Neutral to Buy on August 04, 2026. Market Context BBB Foods Inc.
Read moreRating Change JP Morgan analysts reiterated a Overweight rating on Alignment Healthcare, Inc. (NASDAQ:ALHC) on August 04, 2026. Market Context Alignment Healthcare, Inc.
Read moreRating Change Truist Securities analysts reiterated a Buy rating on DTE Energy Company JR SUB DB 2017 E (NYSE:DTW) on August 04, 2026. Market Context DTE Energy Company JR SUB DB…
Read moreRating Change JP Morgan analysts reiterated a Neutral rating on Penske Automotive Group, Inc. (NYSE:PAG) on August 04, 2026. Market Context Penske Automotive Group, Inc.
Read moreRating Change Citigroup analysts reiterated a Neutral rating on BXP, Inc. (NYSE:BXP) on August 04, 2026. Market Context BXP, Inc.
Read moreRating Change Morgan Stanley analysts reiterated a Equal-Weight rating on EPAM Systems, Inc. (NYSE:EPAM) on August 04, 2026. Market Context EPAM Systems, Inc.
Read moreRating Change JP Morgan analysts reiterated a Underweight rating on UDR, Inc. (NYSE:UDR) on August 04, 2026. Market Context UDR, Inc.
Read moreRating Change Citizens analysts downgraded eBay Inc. (NASDAQ:EBAY) from Market Outperform to Market Perform on August 04, 2026. Market Context eBay Inc.
Read moreRating Change JP Morgan analysts reiterated a Overweight rating on Yum! Brands, Inc. (NYSE:YUM) on August 04, 2026.
Read moreRating Change Barclays analysts reiterated a Overweight rating on aTyr Pharma, Inc. (NASDAQ:LIFE) on August 04, 2026. Market Context aTyr Pharma, Inc.
Read moreRating Change Baird analysts reiterated a Outperform rating on aTyr Pharma, Inc. (NASDAQ:LIFE) on August 04, 2026. Market Context aTyr Pharma, Inc.
Read moreRating Change Citizens analysts reiterated a Market Outperform rating on aTyr Pharma, Inc. (NASDAQ:LIFE) on August 04, 2026. Market Context aTyr Pharma, Inc.
Read moreRating Change Citigroup analysts reiterated a Buy rating on aTyr Pharma, Inc. (NASDAQ:LIFE) on August 04, 2026. Market Context aTyr Pharma, Inc.
Read moreRating Change UBS analysts reiterated a Buy rating on Generac Holdings Inc. (NYSE:GNRC) on August 04, 2026. Market Context Generac Holdings Inc.
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on August 04, 2026. Market Context Vertex…
Read moreRating Change Canaccord Genuity analysts reiterated a Hold rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on August 04, 2026. Market Context Vertex Pharmaceuticals…
Read moreRating Change TD Cowen analysts reiterated a Buy rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on August 04, 2026. Market Context Vertex Pharmaceuticals Incorporated…
Read moreRating Change Keybanc analysts reiterated a Overweight rating on Welltower Inc. (NYSE:WELL) on August 04, 2026. Market Context Welltower Inc.
Read more